Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate + sulfadoxine/pyrimethamine for uncomplicated falciparum malaria in Somalia
ACTRN12611001009909Phase 4Completed
- Sponsor
- Ministry of Health
- Start
- Jul 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artesunate, sulfadoxine and pyrimethamine in malaria and Malaria, sponsored by Ministry of Health. Primary endpoint: Treatment failure rate. Started Jul 2011; status: completed.
02
Drugs
artesunatesulfadoxinepyrimethamine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12611001009909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001009909.